<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="106053">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02116062</url>
  </required_header>
  <id_info>
    <org_study_id>5540</org_study_id>
    <nct_id>NCT02116062</nct_id>
  </id_info>
  <brief_title>Robotic Surgery of the Ocular Surface</brief_title>
  <official_title>Robotic Microsurgery of the Ocular surfaceProspective Human Feasibility Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <authority>France: Agence Nationale de Sécurité du Médicament et des produits de santé</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The introduction of surgical robots in the OR revolutionized a number of specialties (i. e.
      urology, gynecology, digestive surgery). Robots are currently used in many situations and
      the list of appropriate indications is growing rapidly. There are many potential advantages
      of robotics in eye surgery such as increased precision and maneuverability, better
      ergonomics, improved patient access to surgeons and surgical training. As a result, robotics
      might improve patient care. The Da Vinci© robot has been used for 10 years in experimental
      conditions to suture corneal lacerations, to perform corneal grafts, to remove ocular
      foreign bodies, lens capsules and vitreous.
      
                 The authors reported a lack of precision resulting from poor visualization and
      the absence of microsurgical instruments. These elements were considered to be hurdles to
      further clinical investigation. The new Da Vinci Si HD© robot has been available since 2009
      at the IRCAD center and more recently in Strasbourg University Hospital. It provides greater
      magnification and better resolution of the operative field than the previous model. We
      performed since 2012 various ocular surface surgeries on porcine eyes at the IRCAD center.
      The aim of the present trial is to perform the same procedures (amniotic membrane
      transplantations, pterygium surgeries, corneal grafts) in a clinical setting with the Da
      Vinci Si HD© system.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>June 2014</start_date>
  <completion_date type="Anticipated">March 2016</completion_date>
  <primary_completion_date type="Anticipated">July 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Respect for different phases of the operating procedure of each intervention.</measure>
    <time_frame>At the end of the surgery</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Surgeons will check that all steps of the surgery have been done and successfully completed (thanks to a surgery ckeck-list procedure and video tape)</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Keratitis</condition>
  <condition>Pterygium</condition>
  <condition>Corneal Opacity Corneal Thinning</condition>
  <condition>Corneal Perforation</condition>
  <arm_group>
    <arm_group_label>Amniotic membrane transplantation</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Pterygium surgery</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Penetrating keratoplasty</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>1. Amniotic membrane transplantation on the cornea with the Da Vinci Si HD© robot (Inlay or overlay technique)</intervention_name>
    <arm_group_label>Amniotic membrane transplantation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pterygium removal and autograft of the conjunctiva with the Da Vinci Si HD© robot (Kenyon technique)</intervention_name>
    <arm_group_label>Pterygium surgery</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Penetrating keratoplasty using Baron trephine and nylon stitches with the Da Vinci Si HD© robot</intervention_name>
    <arm_group_label>Penetrating keratoplasty</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patient &gt; 18 year-old suffering :

        symptomatic pterygium

          -  chronic corneal ulceration resistant to medical treatment

          -  corneal opacity involving corneal stroma and corneal endothelium

          -  corneal thinning

          -  corneal perforation

        Exclusion Criteria:

          -  History of eye surgery

          -  psychiatric disease

          -  mental deficiency

          -  pregnancy

          -  nursing mother
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bourcier Tristan, PHMD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Les Hôpitaux Universitaires de Strasbourg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Geiller Christine</last_name>
    <phone>0033388115266</phone>
  </overall_contact>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 14, 2014</lastchanged_date>
  <firstreceived_date>February 24, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Corneal Opacity</mesh_term>
    <mesh_term>Keratitis</mesh_term>
    <mesh_term>Pterygium</mesh_term>
    <mesh_term>Corneal Perforation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
